A Retrospective Chart Review Study of the Outcomes of 2nd Line Therapy With LEn/Dex in Greek Patients With R/R Multiple MyEloma and the Treatment PatterNs Following Progressive Disease
Clinical trial NCT02608515 · COMPLETED
Trial details
- NCT number
- NCT02608515
- Sponsor
- Genesis Pharma S.A.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-12-01
- Primary completion
- 2016-09-01
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.